Zobrazeno 1 - 10
of 40
pro vyhledávání: '"M L Powell"'
Autor:
Geoffrey M. L. Powell
Publikováno v:
Annales de l'Institut Fourier
Annales de l'Institut Fourier, Association des Annales de l'Institut Fourier, 2019, 69 (5), pp.2169-2204. ⟨10.5802/aif.3292⟩
Annales de l'Institut Fourier, Association des Annales de l'Institut Fourier, 2019, 69 (5), pp.2169-2204. ⟨10.5802/aif.3292⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1b846539b71cfc39c5aeaf136bcd268
https://hal.archives-ouvertes.fr/hal-02324705
https://hal.archives-ouvertes.fr/hal-02324705
Publikováno v:
International Journal of Osteoarchaeology. 17:327-336
Autor:
Geoffrey M. L. Powell
Publikováno v:
Annales de l’institut Fourier. 50:781-805
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 706:287-294
Two simple and sensitive reversed-phase high-performance liquid chromatography (HPLC) methods were developed and validated for the quantitative determination of a novel hypertension drug CGS 25462 and its major metabolites CGS 24592 and CGS 25659 in
Autor:
Geoffrey M. L. Powell
Publikováno v:
Communications in Algebra. 25:979-987
Autor:
Alexandra Cipriano, Brian Walter, M. L. Powell, George A. Digenis, U. Yun Ryo, Jim X. Sun, Keith Chan, Richard C. Page, Erik P. Sandefer, Wieslawa Maniara
Publikováno v:
The Journal of Clinical Pharmacology. 36:230-237
The gastrointestinal absorption of a hypolipidemic agent (CGP 43371) was investigated using an external scintigraphy technique in six healthy men. After an overnight fast, subjects received a single 800-mg oral dose of CGP 43371 (4 capsules of 200 mg
Publikováno v:
Biomedical Chromatography. 8:247-250
A quantitative analytical method for the determination of a new thromboxane synthetase inhibitor (CGS 22652) in human plasma has been developed using high performance liquid chromatography (HPLC). The drug and internal standard (CGS 23298) were extra
Autor:
M L, POWELL, J G, WHITAKER
Publikováno v:
The Medical journal of Australia. 1
Publikováno v:
Biomedical Chromatography. 6:244-247
CGS 18102A is a novel hexahydrobenzopyranopyridine that has a mixed pharmacological profile of 5-HT-1A agonist and 5-HT-2 antagonist properties. Based upon these mechanisms, the compound is predicted to have anxiolytic efficacy with possible efficacy
The tribological behaviour of two material pairs was explored for the application of metal-metal cervical disc replacement Efforts are being made to find a material pair that minimizes wear while at the same time permitting acceptable postoperative i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b513d43a99832e4d4670dc992725fe53
https://doi.org/10.1016/s0167-8922(05)80087-2
https://doi.org/10.1016/s0167-8922(05)80087-2